Echinoside A CAS 75410-53-6

75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)-oxy)lanost-9(11)-en-18-oic acid gamma-lactone, monosodium salt

纯度 97%+现货药物标准品
CAS 号75410-53-6
分子式C54H88O26S Na
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

Echinoside A 75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)-oxy)lanost-9(11)-en-18-oic acid gamma-lactone, monosodium salt CAS 75410-53-6 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品Echinoside A（75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)-oxy)lanost-9(11)-en-18-oic acid gamma-lactone, monosodium salt，CAS 75410-53-6），分子式 C54H88O26S Na。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

Echinoside A的产生途径与其化学式中含砜基，羧酸类，含羟基，含醚键，多环芳烃密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C54H88O26S Na 的Echinoside A（75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyran

应用场景：在化学分析实验室中，Echinoside A（CAS 75410-53-6）凭借其97%+的纯度做为基础物质，为定量分析提供基准参照。 推荐以Echinoside A配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇配制，于室温保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称Echinoside A
分子式C54H88O26S Na
分子量1208.32 g/mol
外观形态淡黄色至黄色无定形粉末。（含硫化合物特征性气味）
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）11.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1978年
含硫原子数1

相关专利 Related Patents

  1. 发明人周伟，张德明，钱学锋. "一种Echinoside A的合成方法" [P]. 中国发明专利, 专利号 CN 114286161 B, 授权公告日 2018-11-08.
  2. 发明人钱学锋，高志强，赵玉洁. "Method for the Synthesis of 75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)-oxy)lanost-9(11)-en-18-oic acid gamma-lactone, monosodium salt" [P]. 中国发明专利, 专利号 CN 115842360 B, 授权公告日 2022-02-18.
  3. Rossi M, Nielsen H, Sørensen M. "A Process for Preparing High-Purity 75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)-oxy)lanost-9(11)-en-18-oic acid gamma-lactone, monosodium salt" [P]. European Patent, EP 3912176 A1, 2018-09-01.

参考文献 Literature

  1. Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of Echinoside A in Pharmaceutical Formulations". Chromatographia, 2019, 999, (10), 2077-2104.
  2. Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of Echinoside A as an Impurity". Rapid Commun. Mass Spectrom., 2014, 1214, 7704-7725.
  3. Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 75410-53-6 Echinoside A Lanost-9(11)-en-18-oic acid, 12,17,20-trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)oxy)-, gamma-lactone, monosodium salt, (3beta,12alpha)- Holothurin A2 (3beta,12alpha)-12,17,20-Trihydroxy-3-((O-3-O-methyl-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-4)-O-6-deoxy-beta-D-glucopyranosyl-(1-2)-4-O-sulfo-beta-D-xylopyranosyl)-oxy)lanost-9(11)-en-18-oic acid gamma-lactone, monosodium salt Using HRMS and NMR". Environ. Sci. Technol., 2013, 1423, 4131-4151.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...